CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules

Read the official FDA notice

Published
3 Sept 2025
Units affected
8544 bottles
Agency
FDA
Country
United States

The hazard

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37

Brand / company
Lannett Company Inc.
Codes / lots
Lot #: 25280726A, Exp. Date 03/2027
Distribution
Nationwide within the USA
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 3 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.